Favourable outcome in Sickle cell stroke with use of nitric oxide

Abstract

Introduction Stroke in Sickle cell Disease (SCD) is common, frequently recurrent, peaks in late childhood and can cause profound neurological deficits. The mechanism is thought to involve abnormal adherence of sickled cells to the vascular endothelium and as a result of haemolysis stimulating endothelial cell activation, hypercoaguability and alterations in vasomotor tone. Nitric Oxide is a free radical and potent vasodilator which can decrease platelet activation, adhesion receptor expression on the vascular endothelium and vascular smooth muscle proliferation, affecting ischemia-reperfusion injury, modulating endothelial proliferation, and regulating inflammation. Case History We present a 12 year old girl with SS disease on a transfusion programme (Hbs Conclusion This case report presents additional anecdotal evidence that NO therapy has a potential role in management of SS related stroke and justifies additional trials to evaluate its potential role Discussion Inhaled nitric oxide could be beneficial in treatment of stroke in sickle cell disease, by increasing nitric oxide bioavailability, improving blood flow and oxygenation by preventing erythrocyte, platelet, and leukocyte adhesion to the vascular endothelium. Our case demonstrated a dramatic clinical and radiological recovery following the nitric oxide administration and therefore more studies are needed to research its usefulness in comparison with conventional management like exchange transfusion. Abbreviations SS: Sickle cell anaemia; EDAS: Encephalo-duro-arterio-synangiosis